Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 2
Submit an article Journal homepage
28
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prediction of response to imatinib in patients with chronic myelogenous leukemia by flow cytometric analysis of bone marrow blastic cell phenotypes

Satoko Oka Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Kazuo Muroi Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, JapanCorrespondence[email protected]
, MD,
Masaki Mori Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Tomohiro Matsuyama Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Shin-Ichiro Fujiwara Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Iekuni Oh Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Kazuya Sato Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Satoru Kikuchi Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Masuzu Ueda Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Masaki Toshima Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Takahiro Suzuki Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Katsutoshi Ozaki Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
,
Tadashi Nagai Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
&
Keiya Ozawa Division of Hematology, Department of Medicine, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
 show all
Pages 290-293 | Received 06 Sep 2008, Accepted 15 Nov 2008, Published online: 01 Jul 2009

References

  • Kavalerchik E, Goff D, Jamieson C H. Chronic myeloid leukemia stem cells. J Clin Oncol 2008; 26: 2911–2955
  • Savage D G, Antman K H. Imatinib mesylate-a new oral targeted therapy. N Engl J Med 2002; 346: 683–693
  • Druker B J, Guilhot F, O'Brien S G, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408–2417
  • Baccarani M, Guilhot F, Larson R A, O'Brien S G, Druker B J. Outcomes by cytogenetic and molecular response at 12 and 18 months of imatinib in patients with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) in the IRIS Trial. Blood 2006; 108: 2138
  • Marin D, Milojkovic D, Olavarria E, Khorashad J S, de Lavallade H, Reid A G, et al. European LeukemiaNet criteria for failure or sub-optimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor. Blood 2008; 112: 4437–4444
  • Stelzer G T, Shults K E, Loken M R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci 1993; 677: 265–280
  • Borowitz M J, Guenther K L, Shults K E, Stelzer G T. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 1993; 100: 534–540
  • Branford S, Hughes T P, Rudzki Z. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics. Br J Haematol 1999; 107: 587–599
  • Thiele J, Kvasnicka H M, Titius B R, Parpert U, Nebel R, Zankovich R, et al. Histological features of prognostic significance in CML-an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Ann Hematol 1993; 66: 291–302
  • Thiele J, Kvasnicka H M, Schmitt-Graeff A, Zirbes T K, Birnbaum F, Kressmann C, et al. Bone marrow features and clinical findings in chronic myeloid leukemia – a comparative, multicenter, immunohistological and morphometric study on 614 patients. Leuk Lymphoma 2000; 36: 295–308
  • Lamba A, Dey P, Kumari S, Marwaha N. Prognostic significance of the histomorphometric features of bone marrow trephine biopsies in patients with chronic myeloid leukemia. Anal Quant Cytol Histol 2007; 29: 370–376
  • Valent P, Agis H, Sperr W, Sillaber C, Horny H P. Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia. Leuk Lymphoma 2008; 49: 635–658
  • Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2006; 108: 1809–1820
  • Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard M A, et al. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood 2007; 109: 3496–3499
  • Larson R A, Druker B J, Guilhot F, O'Brien S G, Riviere G J, Krahnke T, et al. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood 2008; 111: 4022–4028

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.